Intelligence · Clinical Pipeline
Kura Oncology Pipeline
All ClinicalTrials.gov programs at Kura Oncology — phase, modality, and trial IDs.
- Programs
- 2
Quick answer
Kura Oncology has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
VENETOCLAX, AZACITIDINE, VENETOCLAX, CYTARABINE, Ziftomenib, CYTARABINE, VENETOCLAX, Ziftomenib Placebo, Daunoblastin® 20 mg Pulver zur Herstellung einer Infusions- oder Injektionslösung
Kura Oncology
NPM1-m and KMT2A-r Acute Myeloid Leukemia
1 trial -
Ziftomenib
Kura Oncology
Acute Myeloid Leukemia (AML)
1 trial
Frequently asked questions
How many pipeline programs does Kura Oncology have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs